Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Avraham Pharmaceuticals Ltd

ClinicalTrials.gov Identifier:

NCT01354691

First received: May 1, 2011

Last updated: July 22, 2013

Last verified: July 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2013
Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)